Samsung has announced that its ECG app for their Galaxy Watch 3 and Galaxy Watch Active 2 has received FDA approval in the USA. Samsung has said that the new electrocardiogram tool will soon be ...

Samsung is moving forward with a steady rollout of blood pressure measurement and ECG monitoring on its consumer smartwatches. After securing regulatory approvals and launching the features in South ...

Alongside yesterday's reveal of the Galaxy Watch3, Samsung announced that it has received regulatory clearance from the FDA for its ECG monitoring app. But while the watch – which also has built-in ...

A new continuous glucose monitor (CGM) that is not only non-invasive but that predicts blood sugar levels from ECG data promises to shake up diabetes management. The device is being showcased at the ...

Samsung is enabling ECG monitoring on the Galaxy Watch 3 and Active 2. Your smartwatch can now check for an irregular heartbeat. It’s matching features Apple, Fitbit and others either have or will add ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack ...

Please provide your email address to receive an email when new articles are posted on . Long-term continuous ECG monitoring with human oversight outperformed an artificial intelligence-based mobile ...

Some of the biggest new features on Samsung’s just-announced Galaxy Watch 3 are focused on health. That’s not a huge surprise, given the success Apple has had by making its Watch into a device that ...

The U.S. Food and Drug Administration has cleared Mega Electronics' eMotion ECG monitor to work with Android-based smartphones, Mass Device reported. The Finnish company's device provides real-time ...

A survey of 507 U.S. women found that most were amenable to using wearable electrocardiogram (ECG) technology throughout their pregnancy to monitor maternal and fetal health, according to a UW ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, ...